Join to View Full Profile
281 1st AveNew York, NY 10003
Phone+1 212-420-2000
Dr. Van Oekelen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Multiple myeloma
Education & Training
Icahn School of Medicine at Mount SinaiPhD, Biomedical Sciences, 2018 - 2022- KU Leuven UniversityClass of 2016, MD, summa cum laude
- KU Leuven UniversityClass of 2015, MSc, magna cum laude
- KU Leuven UniversityBSc, Medicine, summa cum laude, 2009 - 2012
Awards, Honors, & Recognition
- Young Investigator Award International Myeloma Society, 2021
- Outstanding Abstract Award American Society of Hematology, 2021
Publications & Presentations
PubMed
- 21 citationsSequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, Jeanne Li, Yogita Ghodke-Puranik
Blood Advances. 2023-03-28 - 1 citationsCharacteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020.Oliver Van Oekelen, Nicole Birrer, William Wesson, Vincent L Galate, Edward R Scheffer Cliff
Blood Cancer Journal. 2022-11-15 - CD8T cells: An ineffective armor against prolonged COVID-19 in cancer patients.Oliver Van Oekelen, Samir Parekh
Cell Reports. Medicine. 2022-07-19
Other Languages
- Dutch, French, German, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
